Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Krüppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation
Chelsea C. Estrada, Praharshasai Paladugu, Yiqing Guo, Jesse Pace, Monica P. Revelo, David J. Salant, Stuart J. Shankland, Vivette D. D’Agati, Anita Mehrotra, Stephanie Cardona, Agnieszka B. Bialkowska, Vincent W. Yang, John C. He, Sandeep K. Mallipattu
Chelsea C. Estrada, Praharshasai Paladugu, Yiqing Guo, Jesse Pace, Monica P. Revelo, David J. Salant, Stuart J. Shankland, Vivette D. D’Agati, Anita Mehrotra, Stephanie Cardona, Agnieszka B. Bialkowska, Vincent W. Yang, John C. He, Sandeep K. Mallipattu
View: Text | PDF
Research Article Nephrology

Krüppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation

  • Text
  • PDF
Abstract

Pathologic glomerular epithelial cell (GEC) hyperplasia is characteristic of both rapidly progressive glomerulonephritis (RPGN) and subtypes of focal segmental glomerulosclerosis (FSGS). Although initial podocyte injury resulting in activation of STAT3 signals GEC proliferation in both diseases, mechanisms regulating this are unknown. Here, we show that the loss of Krüppel-like factor 4 (KLF4), a zinc-finger transcription factor, enhances GEC proliferation in both RPGN and FSGS due to dysregulated STAT3 signaling. We observed that podocyte-specific knockdown of Klf4 (C57BL/6J) increased STAT3 signaling and exacerbated crescent formation after nephrotoxic serum treatment. Interestingly, podocyte-specific knockdown of Klf4 in the FVB/N background alone was sufficient to activate STAT3 signaling, resulting in FSGS with extracapillary proliferation, as well as renal failure and reduced survival. In cultured podocytes, loss of KLF4 resulted in STAT3 activation and cell-cycle reentry, leading to mitotic catastrophe. This triggered IL-6 release into the supernatant, which activated STAT3 signaling in parietal epithelial cells. Conversely, either restoration of KLF4 expression or inhibition of STAT3 signaling improved survival in KLF4-knockdown podocytes. Finally, human kidney biopsy specimens with RPGN exhibited reduced KLF4 expression with a concomitant increase in phospho-STAT3 expression as compared with controls. Collectively, these results suggest the essential role of KLF4/STAT3 signaling in podocyte injury and its regulation of aberrant GEC proliferation.

Authors

Chelsea C. Estrada, Praharshasai Paladugu, Yiqing Guo, Jesse Pace, Monica P. Revelo, David J. Salant, Stuart J. Shankland, Vivette D. D’Agati, Anita Mehrotra, Stephanie Cardona, Agnieszka B. Bialkowska, Vincent W. Yang, John C. He, Sandeep K. Mallipattu

×

Figure 9

Overexpression of KLF4 reduces cytokine-induced STAT3 signaling and cell cycle progression.

Options: View larger image (or click on image) Download as PowerPoint
Overexpression of KLF4 reduces cytokine-induced STAT3 signaling and cell...
(A) Representative Western blot confirms stable overexpression for KLF4 (LentiORF-KLF4) and control vector (LentiORF-RFP) (n = 3). (B) Cell cycle analysis of LentiORF-KLF4 and LentiORF-RFP human podocytes under permissive conditions (n = 3, **P < 0.01; Mann-Whitney U test). (C) Differentiated LentiORF-KLF4 and LentiORF-RFP human podocytes were treated with leukemia inhibitory factor (LIF) (100 ng/ml for 15 minutes) to activate STAT3 signaling, with vehicle (VEH) as control and IL-6 mRNA expression measured (n = 3; **P < 0.01; Mann-Whitney U test). (D) Representative blot of co-IP with initial IP of KLF4 with anti-KLF4 antibody and immunoblotted for phospho-STAT3 (n = 3). IgG isotype serves as control for IP, and GAPDH serves as the loading control. (E) KLF4-shRNA22 podocytes were transfected with LentiORF-KLF4 or LentiORF-RFP, and MTS assay was performed at day 3, 7, and 10 in 37°C (n = 6–10, **P < 0.01 Kruskal-Wallis test with Dunn’s post hoc test).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts